to the protocol
National Biotech Reporter Elaines stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector
In a January note, TD Cowen analysts estimated that retatrutide could rake in sales of $3.8 billion in 2030
Methionine then undergoes a process called the one-carbon cycle to produce S-adenosyl-l-methionine (SAMe), a major methyl donor which plays an essential role in producing neurotransmitters
Beyond GLP-1, the market encompasses peptide cancer therapies (Oncology Peptide Therapy at 4.1% share, 11.79% CAGR), somatostatin analogues for neuroendocrine tumours, GnRH agonists/antagonists for hormone-sensitive cancers, radioligand therapy, and reproductive medicine peptides each representing strategically important niches with their own competitive dynamics
FDA Guidance Documents